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Background
In vivo electroporation (EP) has proven to significantly
increase transfection efficiency and augment immune
responses to plasmid DNA encoded vaccine antigens. In
mice, we have attempted to establish the optimal EP
immunization protocol for delivering HIV-1 antigens.
Methods
Mice were immunized with a plasmid encoding HIV-1 gag
p37, either intradermally (id) with the DermaVax EP
device, or intramuscularly (im) without EP. The different
parameters explored were; the number of immunizations,
the interval between immunizations, and the choice of
priming (im or id). A novel Fluorospot assay was used to
evaluate the vaccine specific cellular immune responses.
This assay allows for detection of vaccine-specific cells
that secrete IFN-γ, IL-2 and cells that simultaneously
secrete both cytokines. In order to verify the Fluorospot
results, conventional ELISpot assay was used. The
humoral vaccine-specific response was evaluated by
ELISA.
Results
The main findings were: 1) two and three id+EP immuni-
zations induced similar and high cellular (up to 8000 IFN-
γ SFC/million splenocytes) responses while antibody
responses were increased after three as compared to two
immunizations, 2) one month interval between immuni-
zations was superior to two months in terms of cellular
responses, and 3) repeated id+EP immunizations induced
higher immune responses than im priming followed by
id+EP boost.
Conclusion
The Fluorospot and the ELIspot assays gave similar results,
confirming the sensitivity of the Fluorospot assay. Moreo-
ver, the Fluorospot assay enabled identification of high
quality vaccine-specific cells simultaneously secreting
both IFN-γ and IL-2. Three id+EP immunizations induced
the highest levels of antibodies, while two immunizations
were sufficient to induce a strong cellular response. In an
upcoming longitudinal study we will further investigate
the capacity of id EP to induce long lasting immune
responses and also investigate the qualitative differences
in responses induced by single vs. multiple immuniza-
tions.
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